Elizabeth L Siegler

6PUBLICATIONS
43CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 12, 2026
The Conflicting Role of Myeloid Cells in CAR T-Cell Therapy.

Grace DeFranco, Elizabeth L Siegler, Saad S Kenderian

|Dec 01, 2025
The Pleiotropic Roles of Cytokines in Chimeric Antigen Receptor T-cell Therapy.

Carli M Stewart, Elizabeth L Siegler, Saad S Kenderian

|Oct 25, 2023
CD19 occupancy with tafasitamab increases therapeutic index of CART19 cell therapy and diminishes severity of CRS.

R Leo Sakemura, Claudia Manriquez Roman, Paulina Horvei

|Jun 28, 2023
AXL Inhibition Improves the Antitumor Activity of Chimeric Antigen Receptor T Cells.

R Leo Sakemura, Mehrdad Hefazi, Michelle J Cox

|Jan 28, 2022
Targeting cancer-associated fibroblasts in the bone marrow prevents resistance to CART-cell therapy in multiple myeloma.

Reona Sakemura, Mehrdad Hefazi, Elizabeth L Siegler

|Jul 10, 2021
Development of a Clinically Relevant Reporter for Chimeric Antigen Receptor T-cell Expansion, Trafficking, and Toxicity.

Reona Sakemura, Aditya Bansal, Elizabeth L Siegler

Pageof 1

Frequent Collaborators

4 joint publications

Claudia Manriquez Roman

4 joint publications

Ismail Can

4 joint publications

Sameer A Parikh

4 joint publications

Neil E Kay